Voyager Therapeutics's market cap is currently $232.71M. The company's EPS TTM is $0.72; its P/E ratio is 5.91; Voyager Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 250.01M	$ 40.91M	$ 37.41M	$ 171.13M	$ 104.39M
Gross Profit	$ 245.57M	$ 34.72M	$ -36.37M	$ 62.38M	$ -15.34M
Operating Income	$ 122.01M	$ -50.84M	$ -73.62M	$ 27.38M	$ -51.68M
EBITDA	$ 126.45M	$ -44.65M	$ -68.45M	$ 31.20M	$ -48.91M
Net Income	$ 132.33M	$ -46.41M	$ -66.03M	$ 36.74M	$ -40.83M
Balance Sheet
Cash & Short-Term Investments	$ 230.88M	$ 118.85M	$ 132.54M	$ 181.14M	$ 281.53M
Total Assets	$ 351.28M	$ 159.36M	$ 193.85M	$ 261.58M	$ 354.76M
Total Debt	$ 20.29M	$ 23.13M	$ 44.18M	$ 47.61M	$ 34.17M
Net Debt	$ -48.51M	$ -75.83M	$ -73.25M	$ -56.83M	$ -51.87M
Total Liabilities	$ 114.96M	$ 100.34M	$ 98.80M	$ 107.26M	$ 255.25M
Stockholders' Equity	$ 236.32M	$ 59.02M	$ 95.06M	$ 154.32M	$ 99.51M
Cash Flow
Free Cash Flow	$ 74.66M	$ -15.00M	$ -55.13M	$ -108.81M	$ 40.95M
Operating Cash Flow	$ 77.92M	$ -12.51M	$ -53.52M	$ -96.72M	$ 48.67M
Investing Cash Flow	$ -141.64M	$ -7.34M	$ 65.91M	$ 113.00M	$ -90.48M
Financing Cash Flow	$ 33.65M	$ 1.11M	$ 612.00K	$ 3.16M	$ 80.99M

Currency in USD

Voyager Therapeutics Earnings and Revenue History

Income Statement >

Voyager Therapeutics Debt to Assets

Balance Sheet >

Voyager Therapeutics Cash Flow

Cash Flow >

Voyager Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing